THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND OSTEOPOROSIS IN THE ELDERLY WOMEN


Authors

  • Anh Ngô Tuấn Đại học Y Dược TP. HCM
  • Đức Nguyễn Minh Đại học Y Dược TP. HCM
  • Ngọc Cao Thanh Đại học Y Dược TP. HCM
  • Công Nguyễn Đức Đại học Y Khoa Phạm Ngọc Thạch
DOI: https://doi.org/10.59354/ydth175.2021.98

Keywords:

Elderly women, metabolic syndomre, osteoporosis

Abstract

Objective: Investigating the association between metabolic syndrome and osteoporosis in the elderly women at Geriatric clinic and Rheumatology clinic of University Medical Center Ho Chi Minh City.

Methods: This cross-sectional study was conducted with the participation of 178 elderly women patients (≥ 60 years of age) at Geriatric clinic and Rheumatology clinic of University Medical Center Ho Chi Minh City from November 2020 to May 2021. Metabolic syndrome was defined using criteria from NCEP/ATP III (National Cholesterol Education Program/Adult Treatment Panel III) in 2005 for Asian people and osteoporosis was diagnosed based on World Health Organization’criteria in 1994 by measuring bone mineral density assessed by dual-energy X-ray absorptiometry.

Results: Of 178 elderly women enrolled the study, we had 82 osteoporotic and 96 non-osteoporotic patients. The prevalence of osteoporosis in metabolic syndrome group was higher than in non-metabolic syndrome group (52,9% versus 26,8%) and statistically significant difference (p = 0,033). In multiple logistic regression analysis, patient with metabolic syndrome increased the odds ratio for osteoporosis by 2,8 times, which was statistically significant (OR = 2.8; p = 0,029). Regarding to the relationship between metabolic syndrome components and osteoporois, waist circumference was negatively associated (OR = 0,95;p = 0,044). Besides, HDL-C also was asociated with osteoporosis in the elderly women (OR = 0,95; p = 0,02).

Conclusion: Metabolic syndrome is positively associated with osteoporosis in the elderly women. Amongst metabolic components, waist circumference and HDL-C are negatively associated with osteoporosis.

References

Hồ Thị Kim Thanh (2013), Nghiên cứu một số đặc điểm dịch tễ, tình trạng kháng insulin và hiệu quả can thiệp ở người cao tuổi mắc hội chứng chuyển hóa, Đại học y Hà Nội,

Hồ Thị Đoan Trinh (2018), “Khảo sát mối liên quan giữa mật độ xương và hội chứng chuyển hóa ở bệnh nhân trên 50 tuổi tại khoa Điều trị đau- Vật lý trị liệu-Y học cổ truyền Bệnh Viện Trưng Vương”. Tạp Chí Y Học TP Hồ Chí Minh,

Trần Thị Thanh Tú (2020), Khảo sát chất lượng cuộc sống và các yếu tố liên quan trên bệnh nhân cao tuổi loãng xương và thiếu xương, Đại học Y Dược Thành phố Hồ Chí Minh,

Ackert-Bicknell C. L. (2012), “HDL cholesterol and bone mineral density: is there a genetic link?”. Bone, 50 (2), pp. 525-33.

Al-Maatouq M. A., El-Desouki M. I., Othman S. A., et al. (2004), “Prevalence of osteoporosis among postmenopausal females with diabetes mellitus”. Saudi Med J, 25 (10), pp. 1423- 7.

Cappuccio F. P., Kalaitzidis R., Duneclift S., Eastwood J. B. (2000), “Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism”. J Nephrol, 13 (3), pp. 169-77.

Chin K. Y., Ima-Nirwana S., Mohamed I. N., et al. (2014), “Insulin-like growth factor-1 is a mediator of age-related decline of bone health status in men”. Aging Male, 17 (2), pp. 102-6.

Chin K. Y., Chan C. Y., Subramaniam S., et al. (2020), “Positive association between metabolic syndrome and bone mineral density among Malaysians”. Int J Med Sci, 17 (16), pp. 2585-2593.

Garg M. K., Marwaha R. K., Tandon N., Bhadra K., Mahalle N. (2014), “Relationship of lipid parameters with bone mineral density in Indian population”. Indian J Endocrinol Metab, 18 (3), pp. 325-32.

Kanis J. A., Johnell O., Oden A., et al. (2000), “Long-term risk of osteoporotic fracture in Malmo”. Osteoporos Int, 11 (8), pp. 669-74.

Kanis John A (1994), “Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report”. Osteoporosis international, 4 (6), pp. 368- 381.

Katayama Y., Akatsu T., Yamamoto M., Kugai N., Nagata N. (1996), “Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia”. J Bone Miner Res, 11 (7), pp. 931-7.

Lin H. H., Huang C. Y., Hwang L. C. (2018), “Association between metabolic syndrome and osteoporosis in Taiwanese middle-aged and elderly participants”. Arch Osteoporos, 13 (1), pp. 48.

Loke S. S., Chang H. W., Li W. C. (2018), “Association between metabolic syndrome and bone mineral density in a Taiwanese elderly population”. J Bone Miner Metab, 36 (2), pp. 200-208.

Muka T., Trajanoska K., Kiefte-de Jong J. C., et al. (2015), “The Association between Metabolic Syndrome, Bone Mineral Density, Hip Bone Geometry and Fracture Risk: The Rotterdam Study”. PLoS One, 10 (6), pp. e0129116.

Thomas G. N., Ho S. Y., Janus E. D., et al. (2005), “The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population”. Diabetes Res Clin Pract, 67 (3), pp. 251-7.

Abstract View: 99
PDF Downloaded: 49

Published

27-06-2023

How to Cite

Ngô Tuấn, A., Nguyễn Minh, Đức, Cao Thanh, N., & Nguyễn Đức, C. (2023). THE ASSOCIATION BETWEEN METABOLIC SYNDROME AND OSTEOPOROSIS IN THE ELDERLY WOMEN. Journal of 175 Practical Medicine and Pharmacy, (27), 12. https://doi.org/10.59354/ydth175.2021.98